Paul A Friedman

Director, Madrigal Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$26.7M

Companies

Latest trade

Jan 9, 2026

Companies

Madrigal Pharmaceuticals, Inc.Director −$26.7M

Trades

MDGL Sold 24,520 shares at $522.39 · planned $12.8M Jan 9

MDGL Sold 280 shares at $551.24 · planned $0.2M Jan 9

MDGL Sold 24,800 shares at $552.18 · planned $13.7M Dec 10

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.